Review
Published on 08 Mar 2023
Key events in cancer: Dysregulation of SREBPs
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1130747
- 4,849 views
- 13 citations
Type at least 3 characters
2,606 articles
Articles
Original Research
Published on 07 Mar 2023
UBA1 inhibition contributes radiosensitization of glioblastoma cells via blocking DNA damage repair
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1073929
- 2,415 views
Review
Published on 07 Mar 2023
Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1079924
- 3,760 views
- 2 citations
Review
Published on 07 Mar 2023
Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1147717
- 5,072 views
- 10 citations
Original Research
Published on 06 Mar 2023
Platycodin-D exerts its anti-cancer effect by promoting c-Myc protein ubiquitination and degradation in gastric cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1138658
- 2,403 views
- 5 citations
Original Research
Published on 06 Mar 2023
A new molecular subclassification and in silico predictions for diagnosis and prognosis of papillary thyroid cancer by alternative splicing profile
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1119789
- 1,620 views
Review
Published on 06 Mar 2023
Current landscape and tailored management of immune-related adverse events
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1078338
- 2,166 views
- 1 citation
Original Research
Published on 03 Mar 2023
Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1137783
- 3,588 views
- 3 citations
Original Research
Published on 03 Mar 2023
Emerging trends and research foci of berberine on tumor from 2002 to 2021: A bibliometric article of the literature from WoSCC
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1122890
- 3,274 views
- 12 citations
Original Research
Published on 02 Mar 2023
Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1118217
- 2,357 views
- 5 citations
Review
Published on 02 Mar 2023
The role of irreversible pan-HER tyrosine kinase inhibitors in the treatment of HER2-Positive metastatic breast cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1142087
- 4,288 views
- 2 citations
Original Research
Published on 02 Mar 2023
Uncovering the mechanism of Kang-ai injection for treating intrahepatic cholangiocarcinoma based on network pharmacology, molecular docking, and in vitro validation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1129709
- 2,375 views
- 4 citations
Original Research
Published on 02 Mar 2023
Integrating network pharmacology prediction and experimental investigation to verify ginkgetin anti-invasion and metastasis of human lung adenocarcinoma cells via the Akt/GSK-3β/Snail and Wnt/β-catenin pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1135601
- 2,412 views
- 7 citations
Original Research
Published on 01 Mar 2023
Integrated analysis of Dendrobium nobile extract Dendrobin A against pancreatic ductal adenocarcinoma based on network pharmacology, bioinformatics, and validation experiments
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1079539
- 3,116 views
- 8 citations
Original Research
Published on 01 Mar 2023
Inhibitory effect and related mechanism of decitabine combined with gemcitabine on proliferation of NK/T cell lymphoma cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1134895
- 2,944 views
- 4 citations
Original Research
Published on 01 Mar 2023
Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1136184
- 2,640 views
- 6 citations